A viral video circulating on social media has reignited questions about the lingering effects of Covid-19 and its vaccines. In the video, a prominent oncologist suggests that spike proteins, either ...

Results from the phase 4 COMPARE study indicate that Nuvaxovid exhibits a more favorable reactogenicity profile compared with the mNEXSPIKE mRNA vaccine.

Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

The heavily mutated new BA.3.2 COVID-19 variant, aka "cicada," is circulating in at least 25 U.S. states, the CDC said. What to know about its spread and symptoms.

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein ...

A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments.

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts of the ...

A new COVID-19 variant, BA.3.2, has been detected in 25 U.S. states, the CDC reports, with immune escape traits that may ...

While the latest variant, called Cicada, carries more mutations, it’s still part of the Omicron family that emerged in 2021.

A variant of COVID-19 called BA.3.2, which has circulated under the radar since late 2024, is now spreading quickly across the United States. As a pulmonary and critical care doctor, I see many ...